Differences

This shows you the differences between two versions of the page.

--- documentation:oncology:meeting_notes_2019_aug-29 [2019/08/30 11:35] – created mgurley
+++ documentation:oncology:meeting_notes_2019_aug-29 [2019/08/30 13:50] (current) – mgurley
@@ Line 4: / Line 4: @@
-    * It was agreed that 'Create ICDO concept for 'Unknown Histology' and precoordinate with all ICDO sites.' is not on the critical path for the symposium.
+    * Robert Miller asked about how code that prepares data for the common ETL input format should deal with ambiguous ICDO site/histology combination in multiple NAACCR schemas.
+      * It was decided that pre-reprocessing code should not consider the ambiguity and rely ETL code to skip ambigious ICDO site/histology combinations.  SQL for identifying NAACCR ambiguities is here: https://github.com/OHDSI/OncologyWG/blob/master/documentation/debug_naaccr_ambiguites.sql
+    * It was agreed that the task 'Create ICDO concept for 'Unknown Histology' and precoordinate with all ICDO sites.' is not on the critical path for the symposium.
       * https://github.com/OHDSI/OncologyWG/issues/67
     * We reviewed the vocabulary tasks necessary for the symposium:
@@ Line 27: / Line 29: @@
     * We discussed timelines for Symposium.
       * Dymytry said that the vocabulary will aim to have the tasks done by 9/5
-      * The group agreed that analysis code should aim to be done by the 9/16
+      * The group agreed that analysis code should aim to be done by the 9/9
-      * The group agreed that ETL work shold aim to be done by 9/16.
+      * The group agreed that ETL work shold aim to be done by 9/9.
     * We discussed Andrew Williams concerns about how to frame the results.
       * The group agreed that we should frame the results as a beta test proof-of-concept.  That many problems, flaws and challenges exist but that have a version 1 accomplished.